Market Closed -
Other stock markets
|
5-day change | 1st Jan Change | ||
2.65 USD | -13.40% | -7.34% | -21.13% |
May. 14 | Poseida Therapeutics Q1 Net Loss Narrows, Revenue Rises | MT |
May. 14 | Earnings Flash (PSTX) POSEIDA THERAPEUTICS Reports Q1 Revenue $28.1M | MT |
This article is reserved for members
Already a member?
Log InNot a member ?
Free registrationEPS Revisions
1st Jan change | Capi. | |
---|---|---|
-21.13% | 297M | |
+16.73% | 121B | |
+13.04% | 107B | |
-5.80% | 24.82B | |
+1.69% | 22.48B | |
-10.09% | 18.32B | |
-40.52% | 16.33B | |
-14.00% | 15.31B | |
+1.18% | 14.08B | |
+24.18% | 11.74B |
- Stock Market
- Equities
- PSTX Stock
- News Poseida Therapeutics, Inc.
- Cantor Fitzgerald Starts Poseida Therapeutics at Overweight with $24 Price Target